2020
DOI: 10.1002/cbic.202000437
|View full text |Cite
|
Sign up to set email alerts
|

Noncanonical Amino Acids in Synthetic Biosafety and Post‐translational Modification Studies

Abstract: The incorporation of noncanonical amino acids (ncAAs) has been extensively studied because of its broad applicability. In the past decades, various in vitro and in vivo ncAA incorporation approaches have been developed to generate synthetic recombinant proteins. Herein, we discuss the methodologies for ncAA incorporation, and their use in diverse research areas, such as in synthetic biosafety and for studies of post‐translational modifications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…An alternative approach for studying PTMs with the potential of both in vitro and in vivo assays relies on the genetic code expansion technology (Chin, 2014; Liu & Schultz, 2010; Mukai et al, 2017), which is based on the natural protein translation machinery and allows genetic and site‐specific incorporation of unnatural amino acids (UAAs) bearing PTMs or their mimics into proteins during translation (Chen et al, 2018; Gang & Park, 2021). Typically, the genetic code expansion system requires the introduction of an orthogonal aminoacyl‐tRNA synthetase/tRNA pair originally from archaebacteria or Escherichia coli ( E. coli ) into the host cells or organisms together with the gene of interest that carries a premature nonsense codon (e.g., the UAG amber codon) at the target site.…”
Section: Introductionmentioning
confidence: 99%
“…An alternative approach for studying PTMs with the potential of both in vitro and in vivo assays relies on the genetic code expansion technology (Chin, 2014; Liu & Schultz, 2010; Mukai et al, 2017), which is based on the natural protein translation machinery and allows genetic and site‐specific incorporation of unnatural amino acids (UAAs) bearing PTMs or their mimics into proteins during translation (Chen et al, 2018; Gang & Park, 2021). Typically, the genetic code expansion system requires the introduction of an orthogonal aminoacyl‐tRNA synthetase/tRNA pair originally from archaebacteria or Escherichia coli ( E. coli ) into the host cells or organisms together with the gene of interest that carries a premature nonsense codon (e.g., the UAG amber codon) at the target site.…”
Section: Introductionmentioning
confidence: 99%